chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting about 9 pm on 9-19, I had extreme diarrhea. Then in the next hour or so, I started having really bad aches and chills. About 10:30 I threw up a lot, everything in my stomach from dinner and all that I had to drink. I was up all night throwing up and having diarrhea. I started having a fever of 102 around 3 AM on 9-20. From 9 PM on 9-19 to about 11 PM on 9-20, I threw up 12 times and had diarrhea about 8 or so times. I was not able to keep down any liquids or food and my body was aching so bad that I could not move. Because of not being able to keep down any fluids (and having a fever and sweating a lot) and also breastfeeding, I felt like I was seriously dehydrated and that I should see a doctor. I called my 24/7 nurse hotline around 8 PM on 9-20 through my insurance company, and the nurse instructed me to go into the ER within the next hour, as I was probably severely dehydrated. I told myself if I threw up in the next 2 hours, that I would go in. I was able at that point to hold down a little bit of water and didn't end up going in, although I probably should have. I felt slightly better on 9-21, but still very weak and dehydrated.
Syncope episode, lightheaded, pale face. Pt laid down for 15 mins & sat for 5 before leaving office. No treatment needed.
Child has acute onset total body urticaria and pruritus. No lip swelling. No difficulty breathing.
Screaming, irritability, wouldn't nurse- lasted about 3 ours. Brought into office. Normal exam except irritability and crying.
Received her first dose, she was breastfeeding; had some projectile vomiting; He was vomiting all day; 'he did not take anything all day'; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 30Jul2021 (Lot number: EW0181) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPOSURE VIA BREAST MILK (non-serious), outcome "unknown", described as "Received her first dose, she was breastfeeding"; VOMITING PROJECTILE (non-serious), outcome "unknown", described as "had some projectile vomiting; He was vomiting all day"; EATING DISORDER (non-serious), outcome "unknown", described as "'he did not take anything all day'". Additional Information: The reporter (mother) received her first dose, she was breastfeeding. and the mother experienced after the first dose some soreness towards her arm and shoulder and she said that her baby also had a reaction from the breastfeeding and had some projectile vomiting." Reporter stated, "So on the first shot that she got, her baby, "he did not take anything all day', he was vomiting all day.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101192775 Mother's case (2 dose)
Redness and itching at site; Redness and itching at site; lump in arm; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient (Non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot: Number: Unknown) dose 1 via an unspecified route of administration, administered in left arm on 02Feb2021 16:30 (at the age of 42-years-old) as single dose for COVID-19 immunization. Medical history included ankylosing spondylitis, allergies to penicillins, COVID-19 (prior vaccination). The patient was not allergic to food and other products. Concomitant medication(s) included adalimumab (HUMIRA), vitamin b complex (VIT B COMPLEX), quercetin, ergocalciferol (VIT D), and multi-vitamin, all received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced redness and itching at site, lump in arm on 05Feb2021 06:00. No treatment was received for the adverse event. The patient had not tested for COVID-19 since vaccination. The outcome of the events was not recovered.  Follow-up attempts have been completed and no further information is expected.
Left arm just above elbow is very red, warm and swollen which began 2 days ago. Not in deltoid where Tdap was given 1/26/10. Patient with no complaint of pain at site, he continues to do push ups and weight lifting.
This spontaneous report was received from a Licensed Practical Nurse regarding an unspecified number of patient of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date, the patients were vaccinated with improperly stored VAQTA lot # L004743, and expiration date- 01-JUN-2017 and lot # L017757, expiration date-08-APR-2018. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
diarrhea; whole body ached; felt cold; felt like the flu; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN (whole body ached), FEELING COLD (felt cold), INFLUENZA LIKE ILLNESS (felt like the flu) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIARRHOEA (diarrhea), PAIN (whole body ached), FEELING COLD (felt cold), INFLUENZA LIKE ILLNESS (felt like the flu) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), PAIN (whole body ached), FEELING COLD (felt cold), INFLUENZA LIKE ILLNESS (felt like the flu) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Imodium.
Patient reported:  fever, nausea, shivvering, fatigue, body aches, and a sore arm. The reaction started the evening after receiving the vaccine and continued for 3 days. She did not seek medical attention, took acetaminophen for body aches.
01/16/2021 Vaccination. About 24 hours later, I started to experience the fever, nausea and HA. The fever lasted for at least 20-3 days, the nausea for 10 days and the HA for about 30 days. I took HA medicine, ice packs on head.
Fever Strong shivering Soreness in joints Pain when taking a deep breath 6-8 hour duration General malaise (24 hour duration)
Pt received JJ vaccination, sat in the observation area for 15 minutes, when his 15 minute observation time lapsed the patient got up to leave and I noted pt walking towards the exit with a staggered gait. I immediately asked the patient if he was ok and got him seated. Pt noted to be diaphoretic with no signs of distress. Pt was breathing and speaking in clear complete sentences and denied chest pain, shortness of breath and swelling to the mouth/ throat. Pt stated he started to experience tunnel vision when he got up and felt dizzy. Its vitals were taken and noted to be stable. I offered to call EMS which patient declined. Pt drank water and ate chips while being observed and vitals were repeated approximately 10 mins later at which time patients vitals were stable and diaphoresis resolved. While patient was being monitored I noted he seemed to be experiencing nasal congestion and left eye watering. Pts lungs remained clear to auscultation bilaterally. I offered to call EMS again and pt agreed. I called EMS who arrived approximately 4 mins later. Pt was evaluated by EMS and taken to local hospital with a stable disposition.
Pt. states that after receiving the 1st dose of Phizer 08/06/2021, started experiencing symptoms 08/07/2021 of blurred vision, slight headache, and pain in the eyes. Primary visit with recommendations of Eye Doctor visit. Developed Shingles diagnosed by ER.
Extreme Fatigue beginning in the early evening of October 9 and continuing throughout the following day; shivering/chills on the evening of October 9; increased body temperature beginning late evening of October 9 and continuing into the next day; body weakness starting on October 10. ? Same symptoms when first dose of Shingrix taken on July 10, 2020.  It seems to me that the dosage administered was too strong.
Large red swollen injection reaction measuring 15.5 cm X 12 cm in size 72 hour after shot and still enlarging. Also warm to touch.
pt recvd vax & became febrile in pm; t 104; mom gave apap & temp came down; afebrile today;
Subsequent to receiving Tetanus and Diphtheria Toxoids Adsorbed Purogenated pt developed erythema multiforme.
Left thigh swelling and redness as per parents; Came into office to see M.D.; Swelling and redness resolved.
Starting with headaches, injection site soreness, swollen lymph nodes in arm of injection, treated by ibuprofen, about 12 hours after the vaccine About 16 hours after the vaccine fever, chills, muscle aches, nausea, vomiting,  headaches, lymph node soreness lasting 12+ hours 2nd day after vaccine intense fatigue and headaches, arm and lymph node soreness 3rd day after the vaccine , headaches and arm/lymph node soreness 4th day after the vaccine, arm and lymph node soreness
Initial report received from a HCP on 14 Dec 2009. This patient inadvertently received a 0.5 mL IM dose of FLUVIRIN intranasally instead of intramuscularly on 14 Dec 2009. No adverse effects were noted upon administration.
24 hrs., mild fever, muscle headache, and brain fog, and exhaustion. End of July 2021, things looked wavy, and distorted, and greyed out circle, and double vision. 9 Aug 2021, I went to see the doctor; Diagnosed white dots syndrome on left eye for 11 weeks now. Loss of central vision, just saw a circle, caused by a virus beforehand similar like an auto-immune response. MEWDS. It's still improving and not fully recovered.
pt recv vax 21FEB97 & exp flu like sx w/in 24-48hr post vax;sx were resolving @ the time of this report 24FEB97;pt did not seek med attention to treat the events;
Pt recvd vax & state had devel really bad hives by 26DEC92 just finished PCN a/vax;
Within 5 mins of vaccine I felt my chest tightening.  I could still breathe but I could tell my lungs were tight.  Taking a deep breath was not normal.    Soon after I felt the muscles between my shoulder blades starting to tighten as well.  I think a response to my tightness in my chest.    We were instructed to stay in facility for 15 mins.  My symptoms did not increase after 15 mins so I went home. That was 5:00pm.  By bedtime at 10:00pm  my symptoms had resolved.    I?m not sure if I should get my second dose?
The pt experienced a prolonged rash at the site of injection. Blisters with a 3 x 4 cm area of redness. No response to antibiotics.
Severe redness and swelling in the area of vaccination. Then the redness started to move down the arm and the back. Appeared like the patient got hit in the arm, black and blue brusing.
Arm and head have hurt enough to prevent sleep. Some 30 hours after innoculation chills and fever were experienced for about an hour.
I received 1st dose on 3/8/2021 and on 3/12/2021, a rash appeared on my forearm of my left arm which was where I received the vaccine, but I received the vaccine in my upper arm.    I received the 2nd dose on 3/29/2021 at 11:30AM and I experienced no adverse effects until 2:45AM.  I woke up with a slight fever, extremely sore joints and my skin, from head to toe was extremely sensitive and felt like I had a sunburn all over.  I continued to have rashes appear different places on my body and while I am no longer having rashes appear, I tend to get very itchy, especially in the evening, which is new for me since receiving the 2nde dose of the vaccine.
Left sided pain to sinus area, dry lips, sinus drainage from left side, ear pain, jaw pain. He still has drainage and pain to left side.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 20-DEC-2014, a healthcare provider at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot# and route not provided). The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. On or about 06-SEP-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Chills, shivering, short of breath, vomiting for 15 minutes, chills for an hour and sweating after that, headache. After vomiting I took a Benedryl and than extra strength Tylenol at night.
COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/27/21 (ER8729) Pfizer Dose 2 5/19/21 (EW0168) COVID Positive 9/16/21  9/22/21: Patient is a 58-year-old male who presented to an outside area emergency room with a roughly 1 week history of increasing fever, chills or night sweats as well as increasing shortness of breath, dyspnea and cough.  There is a recent history of being exposed to COVID via his mother.  The patient takes care of his mother on a regular basis who was known to recently have COVID.  Patient believes his exposure was roughly 7-10 days ago and he started to experience symptoms this past Wednesday and tested positive subsequently on Thursday.  Patient did also receive the immunoglobulin infusion on Monday which he states did help some for about 1 or 2 days after which time he started to feel ill again.  Patient did receive the Pfizer vaccine and did receive both injections.  At home the patient has felt febrile with some vague complaints of malaise, fatigue and weakness with body aches.  There has been increasing shortness of breath and dyspnea as well as an increasing cough.  No chest pain symptoms have been noted.  No recent changes to his medications.  The patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records have been personally reviewed.  Case was also discussed directly with the emergency room provider.  9/25/21: Patient was admitted on September 22, 2021 for evaluation COVID pneumonia.  Patient's COVID pneumonia was managed by antibiotics, remdesivir, Decadron.  Patient was requiring oxygen supplementation throughout most of the hospitalization.  Patient's hospital course was complicated due to the persistent oxygen supplementation.  Patient received a total of 4 days of antibiotics, 4 days of remdesivir, 4 days of Decadron.  A walk test for determination of home oxygen was conducted and determined that the patient did not need any oxygen for home.  Patient will need to complete a 5 day course of Levaquin after discharge.
Severe headache, fatigue, nausea. Administered 9/21/16. Reported by patient 10/4/16.
Information has been received from a consumer concerning a 6 year old male patient who on 26AUG1997 was vaccinated with a first dose of varicella virus vaccine live. Concomitant vaccination included a diphtheria toxoid+pertussis vaccine+tetanus toxoid and a dose of Haemophilus B conjugate vaccine (HIBTITER). On 28MAR2003, the patient developed a "slight break out of the chicken pox virus". The reporter noted that the patient was not brought to see the physician. Follow up information from a woman in a medical office indicated that the patient was not vaccinated at their office, but the office was notified of the patient's experience by the parent. The reporter described the event as a minor case of varicella and noted that this was "not a vaccine reaction". Subsequently in March 2003, the patient recovered. Additional information is not expected.
Fever over 101 degrees, chills, body aches, headache, from 10:30 pm the night of the vaccination. Lethargic, aches, and fever remained for 24 hours. Tylenol was taken 12 hours after the vaccination. All symptoms were resolved within 36 hours.
lt deltoid w/erythema & induration of 3.7 x 2.5cm p/vax 4 days prior;tx DPH & warm compresses;
Got into an accident not long after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose). At the time of the report, ROAD TRAFFIC ACCIDENT (Got into an accident not long after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.   This case was linked to MOD-2021-265617 (Patient Link).
Erythema,edema and tenderness around injection site (Left Deltoid). Also, pain going down to left hand.
BREAKTHROUGH COVID:  Per nurse, the pt states that her abd pain has been present for 1 week with dyspnea today that prompted her call to EMS. Pt does live alone. HPI is otherwise limited due to pt being a poor historian.   Associated symptoms: abdominal pain, shortness of breath, denies chest pain, denies nausea, denies vomiting, denies fever, denies chills and denies dizziness.   Sepsis, Transaminitis Acidosis, lactic, AP (abdominal pain) , Acute COVID-19. Pt is a confirmed hospice patient. Pt expired 6/4/2022.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 3rd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In August 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling, tiredness, injection site itching, general body pain, upset stomach, headache, injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site pain, injection site swelling, tiredness, general body pain, upset stomach, headache, injection site erythema and injection site warmth were recovering/resolving and the outcome of the injection site itching was unchanged. It was unknown if the reporter considered the injection site pain, injection site swelling, tiredness, injection site itching, general body pain, upset stomach, headache, injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 68 or 69 years. On 3rd August 2018, at 11:00 hours, the patient received SHINGRIX in the left arm. After receiving SHINGRIX, the patient experienced pain, redness, swelling, soreness and hot area at the injection site. The red area at the injection site was 5 inches by 2.5 inches in size. The patient also experienced body aches, stomach upset, headache and felt tired. On day 3, the patient experienced itching at the injection site. The patient was scheduled to receive cortisone injections on the day after reporting. The patient had denied permission to contact their physician. No further details were provided. The patient was referred to their health care provider.
Patient presented about 15 min after receiving the vaccine with left arm redness. Patient denies any itching, pain but states it feels warm. Benadryl was given to the patient. Vitals remained stable. Patient was able to ambulate to her car without difficulty.
I suffered from an episode of tacchycardia resulting in admission to the hospital; CT Angio Chest revealed subpleural groundglass opacification in the bilateral lower lobes and in the left upper lobe and right middle lobe most pronounced in the lower lungs; I also had a positive D-Dimer result of 1,250.; chest pains; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8734, Expiration Date: Unknown), via an unspecified route of administration, administered in Arm Left on 03Apr2021 12:00 (age at vaccination 55 years) as dose 1 single for covid-19 immunisation and dose 2 of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0171, Expiration Date: Unknown), via an unspecified route of administration, administered in Arm Left on 24Apr2021 12:00 (age at vaccination 55 years) as dose 2, single for COVID-19 immunisation. Relevant medical history included obesity. The patient received Vitamins within 2 weeks of vaccination. There was no past drug history. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11May2021, the patient began experiencing chest pains. On 10Jun2021 19:00, she suffered from an episode of tachycardia resulting in admission to the hospital, CT Angio Chest revealed subpleural ground glass opacification in the bilateral lower lobes and in the left upper lobe and right middle lobe most pronounced in the lower lungs and she also had a positive D-Dimer result of 1,250. The adverse events were result at Doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events caused hospitalization Prolonged. On 10Jun2021, the patient underwent lab tests and procedures which includes CT Angio Chest revealed subpleural ground glass opacification in the bilateral lower lobes and in the left upper lobe and right middle lobe most pronounced in the lower lungs. She also had a positive D-Dimer result of 1,250. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received the treatment for the events. The outcome of the events was recovering whereas chest pains was unknown.
24 hrs after 2nd dose, (approx. 2pm next day): body flushing and lip tingling noted.  40 hrs after (approx 6am 2 days after 2nd dose): moderate, painful upper lip swelling present for 10-12 hours. Body flushing, hot flashes noted on and off throughout day. Resolved without treatment.
Mild GI symptoms prior to receiving vaccine. By evening N/O diarrhea Friday am T 101F with Tylenol symptoms until Sat. Sun am went to med center. DX bilateral otitis media neg for influenza ATB and cough medicine. Mon better.